Baking soda study for kidney patients pulled before it started
NCT ID NCT03301558
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study was designed to see if taking sodium bicarbonate (a common antacid) could reduce the risk of harmful calcium buildup in the blood vessels of kidney transplant recipients. It planned to give participants either a low or high dose of sodium bicarbonate and measure changes in blood calcification. However, the trial was withdrawn before any patients were enrolled, so no results are available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- sodium bicarbonate (Nephrotrans)
- What this could lead to
- If it had succeeded, this could have pointed toward a simple way to reduce blood vessel calcification in kidney transplant patients.
- What could go wrong
- The trial was withdrawn before enrolling anyone, so no data exist. Even if run, it was a small early-phase study that might not have shown a clear benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT; COMPLICATIONS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ordensklinikum Linz GmbH Elisabethinen
Linz, Upper Austria, 4020, Austria
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a vaccine shield transplant patients from shingles?
- Can a single drug dose forecast transplant kidney health?
- Pre-Surgery bootcamp may boost kidney transplant recovery
- Simple bathroom habit may cut infection risk after kidney transplant
- Urine test may catch kidney rejection before it's too late
- Home workouts could protect kidney transplant Patients' hearts